Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1978 1
1980 1
1981 2
1982 2
1983 3
1984 7
1985 5
1986 8
1987 7
1988 3
1989 5
1990 5
1991 7
1992 12
1993 4
1994 5
1995 4
1996 9
1997 6
1998 13
1999 7
2000 11
2001 6
2002 6
2003 12
2004 7
2005 8
2006 12
2007 13
2008 11
2009 20
2010 11
2011 18
2012 20
2013 36
2014 41
2015 27
2016 13
2017 22
2018 24
2019 25
2020 44
2021 34
2022 26
2023 34
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

533 results

Results by year

Filters applied: . Clear all
Page 1
Continuous glucose monitoring and metrics for clinical trials: an international consensus statement.
Battelino T, Alexander CM, Amiel SA, Arreaza-Rubin G, Beck RW, Bergenstal RM, Buckingham BA, Carroll J, Ceriello A, Chow E, Choudhary P, Close K, Danne T, Dutta S, Gabbay R, Garg S, Heverly J, Hirsch IB, Kader T, Kenney J, Kovatchev B, Laffel L, Maahs D, Mathieu C, Mauricio D, Nimri R, Nishimura R, Scharf M, Del Prato S, Renard E, Rosenstock J, Saboo B, Ueki K, Umpierrez GE, Weinzimer SA, Phillip M. Battelino T, et al. Lancet Diabetes Endocrinol. 2023 Jan;11(1):42-57. doi: 10.1016/S2213-8587(22)00319-9. Epub 2022 Dec 6. Lancet Diabetes Endocrinol. 2023. PMID: 36493795 Review.
The use of this measure highlights the long-established correlation between HbA(1c) and relative risk of diabetes complications; the change in the measure, before and after the therapeutic intervention, is used by regulators for the approval of medications for diabetes. .. …
The use of this measure highlights the long-established correlation between HbA(1c) and relative risk of diabetes complications; the change …
Dietary fibre and whole grains in diabetes management: Systematic review and meta-analyses.
Reynolds AN, Akerman AP, Mann J. Reynolds AN, et al. PLoS Med. 2020 Mar 6;17(3):e1003053. doi: 10.1371/journal.pmed.1003053. eCollection 2020 Mar. PLoS Med. 2020. PMID: 32142510 Free PMC article.
These benefits were not confined to any fibre type or to any type of diabetes and were apparent across the range of intakes, although greater improvements in glycaemic control were observed for those moving from low to moderate or high intakes. Based on these findings, increasing …
These benefits were not confined to any fibre type or to any type of diabetes and were apparent across the range of intakes, although greate …
Guidelines on the diagnosis and treatment of foot infection in persons with diabetes (IWGDF 2019 update).
Lipsky BA, Senneville É, Abbas ZG, Aragón-Sánchez J, Diggle M, Embil JM, Kono S, Lavery LA, Malone M, van Asten SA, Urbančič-Rovan V, Peters EJG; International Working Group on the Diabetic Foot (IWGDF). Lipsky BA, et al. Diabetes Metab Res Rev. 2020 Mar;36 Suppl 1:e3280. doi: 10.1002/dmrr.3280. Diabetes Metab Res Rev. 2020. PMID: 32176444
Of note, we have updated this scheme for the first time since we developed it 15 years ago. We also review the microbiology of diabetic foot infections, including how to collect samples and to process them to identify causative pathogens. ...We think that following the pri …
Of note, we have updated this scheme for the first time since we developed it 15 years ago. We also review the microbiology of diabet …
Management of Type 1 Diabetes With a Very Low-Carbohydrate Diet.
Lennerz BS, Barton A, Bernstein RK, Dikeman RD, Diulus C, Hallberg S, Rhodes ET, Ebbeling CB, Westman EC, Yancy WS Jr, Ludwig DS. Lennerz BS, et al. Pediatrics. 2018 Jun;141(6):e20173349. doi: 10.1542/peds.2017-3349. Epub 2018 May 7. Pediatrics. 2018. PMID: 29735574 Free PMC article.
OBJECTIVES: To evaluate glycemic control among children and adults with type 1 diabetes mellitus (T1DM) who consume a very low-carbohydrate diet (VLCD). ...We assessed current hemoglobin A1c (HbA1c) (primary measure), change in HbA1c after the self-rep …
OBJECTIVES: To evaluate glycemic control among children and adults with type 1 diabetes mellitus (T1DM) who cons …
State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016-2018.
Foster NC, Beck RW, Miller KM, Clements MA, Rickels MR, DiMeglio LA, Maahs DM, Tamborlane WV, Bergenstal R, Smith E, Olson BA, Garg SK. Foster NC, et al. Diabetes Technol Ther. 2019 Feb;21(2):66-72. doi: 10.1089/dia.2018.0384. Epub 2019 Jan 18. Diabetes Technol Ther. 2019. PMID: 30657336 Free PMC article.
RESULTS: Mean HbA1c in 2016-2018 increased from 65 mmol/mol at the age of 5 years to 78 mmol/mol between ages 15 and 18, with a decrease to 64 mmol/mol by age 28 and 58-63 mmol/mol beyond age 30. ...
RESULTS: Mean HbA1c in 2016-2018 increased from 65 mmol/mol at the age of 5 years to 78 mmol/mol between ages 15 and 18, with a decre …
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.
Jellinger PS, Handelsman Y, Rosenblit PD, Bloomgarden ZT, Fonseca VA, Garber AJ, Grunberger G, Guerin CK, Bell DSH, Mechanick JI, Pessah-Pollack R, Wyne K, Smith D, Brinton EA, Fazio S, Davidson M. Jellinger PS, et al. Endocr Pract. 2017 Apr;23(Suppl 2):1-87. doi: 10.4158/EP171764.APPGL. Endocr Pract. 2017. PMID: 28437620
RESULTS: The Executive Summary of this document contains 87 recommendations of which 45 are Grade A (51.7%), 18 are Grade B (20.7%), 15 are Grade C (17.2%), and 9 (10.3%) are Grade D. These detailed, evidence-based recommendations allow for nuance-based clinical decision-m …
RESULTS: The Executive Summary of this document contains 87 recommendations of which 45 are Grade A (51.7%), 18 are Grade B (20.7%), 15 …
Effect of the Ketogenic Diet on the Prophylaxis and Treatment of Diabetes Mellitus: A Review of the Meta-Analyses and Clinical Trials.
Dyńka D, Kowalcze K, Ambrozkiewicz F, Paziewska A. Dyńka D, et al. Nutrients. 2023 Jan 18;15(3):500. doi: 10.3390/nu15030500. Nutrients. 2023. PMID: 36771207 Free PMC article. Review.
Further research is needed in this field, especially studies with a long follow-up period. The discussed articles report interesting therapeutic advantages to the ketogenic diet in comparison with standard diets....
Further research is needed in this field, especially studies with a long follow-up period. The discussed articles report interesting ther …
Safety and Efficacy of Teplizumab for Treatment of Type One Diabetes Mellitus: A Systematic Review and Meta-Analysis.
Nourelden AZ, Elshanbary AA, El-Sherif L, Benmelouka AY, Rohim HI, Helmy SK, Sayed MK, Ismail A, Ali AS, Ragab KM, Zaazouee MS. Nourelden AZ, et al. Endocr Metab Immune Disord Drug Targets. 2021;21(10):1895-1904. doi: 10.2174/1871530320999201209222921. Endocr Metab Immune Disord Drug Targets. 2021. PMID: 33302842
The area under the curve of C-peptide was significantly increased in teplizumab group at 12 months (MD = 0.08, 95% CI [0.01, 0.15], P = 0.03), 18 months (MD = 0.13, 95% CI [0.01, 0.25], P = 0.03) and 24 months (MD = 0.13, 95% CI [0.01, 0.24], P = 0.03). ...
The area under the curve of C-peptide was significantly increased in teplizumab group at 12 months (MD = 0.08, 95% CI [0.01, 0.15], P …
Type 1 diabetes management: Room for improvement.
Varkevisser RDM, Birnie E, Mul D, van Dijk PR, Aanstoot HJ, Wolffenbuttel BHR, van der Klauw MM. Varkevisser RDM, et al. J Diabetes. 2023 Mar;15(3):255-263. doi: 10.1111/1753-0407.13368. Epub 2023 Feb 17. J Diabetes. 2023. PMID: 36808864 Free PMC article.
AIMS/HYPOTHESIS: Optimal diabetes care and risk factor management are important to delay micro- and macrovascular complications in individuals with type 1 diabetes (T1D). ...
AIMS/HYPOTHESIS: Optimal diabetes care and risk factor management are important to delay micro- and macrovascular complications in in …
533 results